These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 16418506

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
    Mauri D, Pavlidis N, Polyzos NP, Ioannidis JP.
    J Natl Cancer Inst; 2006 Sep 20; 98(18):1285-91. PubMed ID: 16985247
    [Abstract] [Full Text] [Related]

  • 3. Alternative to tamoxifen effective for preventing breast cancer recurrence.
    Mayo Clin Womens Healthsource; 2005 May 20; 9(5):3. PubMed ID: 15891689
    [No Abstract] [Full Text] [Related]

  • 4. Preventing relapse beyond 5 years: the MA.17 extended adjuvant trial.
    Goss PE.
    Semin Oncol; 2006 Apr 20; 33(2 Suppl 7):S8-12. PubMed ID: 16730271
    [Abstract] [Full Text] [Related]

  • 5. The use of early adjuvant aromatase inhibitor therapy: contributions from the BIG 1-98 letrozole trial.
    Forbes JF.
    Semin Oncol; 2006 Apr 20; 33(2 Suppl 7):S2-7. PubMed ID: 16730270
    [Abstract] [Full Text] [Related]

  • 6. Resumption of menses with initiation of letrozole after five years of amenorrhea on tamoxifen: caution needed when using tamoxifen followed by aromatase inhibitors.
    Hargis JB, Nakajima ST.
    Cancer Invest; 2006 Mar 20; 24(2):174-7. PubMed ID: 16537187
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anastrozole data show continued delay in relapse, but no clear survival advantage.
    Travis K.
    J Natl Cancer Inst; 2005 Jan 19; 97(2):86-7. PubMed ID: 15657334
    [No Abstract] [Full Text] [Related]

  • 9. Aromatase inhibitors for the treatment of breast cancer: is tamoxifen of historical interest only?
    Van Poznak CH, Hayes DF.
    J Natl Cancer Inst; 2006 Sep 20; 98(18):1261-3. PubMed ID: 16985239
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A review of the BIG results: the Breast International Group 1-98 trial analyses.
    Doughty JC.
    Breast; 2008 Jan 20; 17 Suppl 1():S9-S14. PubMed ID: 18279765
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.
    Monnier AM.
    Expert Rev Anticancer Ther; 2007 May 20; 7(5):627-34. PubMed ID: 17492927
    [Abstract] [Full Text] [Related]

  • 15. Extended adjuvant therapy for breast cancer--how much is enough?
    Prowell TM, Stearns V.
    J Natl Cancer Inst; 2007 Dec 19; 99(24):1825-7. PubMed ID: 18073372
    [No Abstract] [Full Text] [Related]

  • 16. A case of brain metastases from breast cancer that responded to anastrozole monotherapy.
    Ito K, Ito T, Okada T, Watanabe T, Gomi K, Kanai T, Mochizuki Y, Amano J.
    Breast J; 2009 Dec 19; 15(4):435-7. PubMed ID: 19470131
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.